Consolidated Balance Sheets - USD ($) $ in Thousands		Jun. 30, 2023		Dec. 31, 2022
Assets
Cash and cash equivalents		$ 82,257		$ 33,172
Federal funds sold		42,297		72,426
Investment securities		53,692		48,492
Equity investments		11,404		10,293
Loans		2,156,998		1,916,953
Allowance for loan losses		(74,971)	[1]	(63,845)	[2]
Net loans receivable		2,082,027		1,853,108
Goodwill		150,803		150,803
Intangible assets, net		21,315		22,035
Loan collateral in process of foreclosure	[3]	16,803		21,819
Accrued interest receivable		13,345		12,613
Property, equipment, and right-of-use lease asset, net		13,343		13,168
Income tax receivable		2,795		2,095
Other assets		29,056		19,855
Total assets		2,519,137		2,259,879
Liabilities
Deposits	[4]	1,813,785		1,607,110
Long-term debt	[5]	178,128		214,320
Short-term borrowings	[6]	67,880		5,000
Deferred tax liabilities, net		26,840		26,753
Operating lease liabilities		7,629		8,408
Accrued interest payable		4,449		4,790
Accounts payable and accrued expenses	[7]	32,662		22,974
Total liabilities		2,131,373		1,889,355
Commitments and contingencies
Stockholders’ equity
Preferred stock (1,000,000 shares of $0.01 par value stock authorized-none outstanding)		0		0
Common stock (50,000,000 shares of $0.01 par value stock authorized - XX shares at June 30, 2023 and 28,663,827 shares at December 31, 2022 issued)		289		287
Additional paid in capital		285,435		283,663
Treasury stock (5,602,154 shares at June 30, 2023 and December 31, 2022)		(45,538)		(45,538)
Accumulated other comprehensive income (loss)		(3,749)		(3,349)
Retained earnings		82,539		66,673
Total stockholders’ equity		318,976		301,736
Non-controlling interest in consolidated subsidiaries		68,788		68,788
Total equity		387,764		370,524
Total liabilities and equity		$ 2,519,137		$ 2,259,879
Number of shares outstanding		23,345,017		23,061,673
Book value per share		$ 13.66		$ 13.08

[1] As of June 30, 2023 and June 30, 2022, there were no allowance for credit losses and net charge-offs related to the strategic partnership loans.

[2] Represents allowance prior to the adoption of ASU 2016-13.

[3] Includes financed sales of this collateral to third parties that are reported separately from the loan portfolio, of $6.8 million as of June 30, 2023 and $7.5 million as of December 31, 2022.

[4] Includes $3.9 million and $3.8 million of deferred financing costs as of June 30, 2023 and December 31, 2022. Refer to Note 5 for more details.

[5] Includes $2.9 million and $3.2 million of deferred financing costs as of June 30, 2023 and December 31, 2022. Refer to Note 5 for more details.

[6] Includes $28.0 million of borrowings through the Federal Reserve discount window.

[7] Includes the short-term portion of lease liabilities of $2.2 million as of both June 30, 2023 and December 31, 2022. Refer to Note 6 for more details.